HYDRUS Microstent
Device Ophthalmology
PDI 00867487000134
General payments
$10,791,552
Research payments
$3,557,240
Through program year 2025, $10,791,552 in general payments and $3,557,240 in research payments were reported against HYDRUS Microstent (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $823,845 | 5,988 |
| 2025 | Research | $944,843 | 663 |
| 2024 | General | $971,092 | 6,421 |
| 2024 | Research | $989,820 | 765 |
| 2023 | General | $1,101,256 | 6,938 |
| 2023 | Research | $1,094,898 | 465 |
| 2022 | General | $7,895,360 | 4,239 |
| 2022 | Research | $527,679 | 23 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
23,586 general · 1,916 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.